EuclidSR Partners
North America, New York, United States, New York
Description
Successful venture investing combines two essential components: finding opportunities with significant growth potential and helping to
Investor Profile
EuclidSR Partners has backed more than 19 startups, with 0 new investments in the last 12 months alone. The firm has led 4 rounds, about 21% of its total and boasts 9 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series Unknown, Series B rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
Stage Focus
- Series C (26%)
- Series Unknown (16%)
- Series B (16%)
- Series E (16%)
- Series D (11%)
- Private Equity (5%)
- Post Ipo Equity (5%)
- Series A (5%)
Country Focus
- United States (95%)
- United Kingdom (5%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Life Science
- Genetics
- Emergency Medicine
- Business Intelligence
- Information Technology
- Medical
- Biopharma
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does EuclidSR Partners frequently co-invest with?
What are some of recent deals done by EuclidSR Partners?
Find More Investors Like EuclidSR Partners
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides










